Vet Pathol Download to Citation Manager
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muto, T.
Right arrow Articles by Furusato, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muto, T.
Right arrow Articles by Furusato, M.
Vet Pathol 37:248-253 (2000)
© 2000 American College of Veterinary Pathologists

p53 Gene Mutations Occurring in Spontaneous Benign and Malignant Mammary Tumors of the Dog

T. Muto, S. Wakui, H. Takahashi, S. Maekawa, T. Masaoka, S. Ushigome and M. Furusato

Department of Experimental Pathology, Comparative Toxicology Laboratories, School of Veterinary Medicine, Azabu University, Kanagawa, Japan (TMuto, SW, TMasaoka); Department of Pathology, School of Medicine, The Jikei University, Minatoku, Tokyo, Japan (SW, HT, SU); and Department of Pathology, School of Medicine, Kyorin University, Mitakashi, Tokyo, Japan (SW, SM, MF)

Sixty-three cases of benign and malignant canine mammary tumors were analyzed to define the alteration of exons 5–8 for the p53 tumor suppressor gene using polymerase chain reaction direct sequence analysis with paraffin-embedded tissues. Four missense mutations were found in 38 benign mammary tumors (11%), and five missense (one tumor had two missense mutations) and one nonsense mutations were found in 25 mammary carcinomas (20%). These data suggest that the p53 gene alterations might be initiated at an early stage of canine mammary carcinogenesis and p53 mutations might be associated with malignancy. However, there was no evidence of any relationship between the p53 alterations and the histologic types of tumors or breeds of dogs.


Key words: Dogs; mammary neoplasms; mutation; p53; tumor suppressor gene.

Address reprint requests to Dr. S. Wakui, Comparative Toxicology Laboratories, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 229-8501 (Japan). E-mail: wakui{at}azabu-u.ac.jp.




This article has been cited by other articles:


Home page
Vet PatholHome page
T. Carvalho, H. Vala, C. Pinto, M. Pinho, and M. C. Peleteiro
Immunohistochemical Studies of Epithelial Cell Proliferation and p53 Mutation in Bovine Ocular Squamous Cell Carcinoma
Vet. Pathol., January 1, 2005; 42(1): 66 - 73.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
G. Stoica, H.-T. Kim, D. G. Hall, and J. R. Coates
Morphology, Immunohistochemistry, and Genetic Alterations in Dog Astrocytomas
Vet. Pathol., January 1, 2004; 41(1): 10 - 19.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
P. Loukopoulos, J. R. Thornton, and W. F. Robinson
Clinical and Pathologic Relevance of p53 Index in Canine Osseous Tumors
Vet. Pathol., May 1, 2003; 40(3): 237 - 248.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. Dore, I. Lanthier, and J. Sirois
Cyclooxygenase-2 Expression in Canine Mammary Tumors
Vet. Pathol., March 1, 2003; 40(2): 207 - 212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Veterinary Pathologists.